Investor Kurma Partners raises €140M for latest Europe-focused biotech fund
Kurma Partners has closed the first part of its latest biotech-focused fund, following a pair of M&A exits for drug developers backed by its third …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
